These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 3026622

  • 1. Human brain tumor-associated urinary high molecular weight transforming growth factor: a high molecular weight form of epidermal growth factor.
    Stromberg K, Hudgins WR, Dorman LS, Henderson LE, Sowder RC, Sherrell BJ, Mount CD, Orth DN.
    Cancer Res; 1987 Feb 15; 47(4):1190-6. PubMed ID: 3026622
    [Abstract] [Full Text] [Related]

  • 2. Urinary transforming growth factors in neoplasia: separation of 125I-labeled transforming growth factor-alpha from epidermal growth factor in human urine.
    Stromberg K, Hudgins WR.
    Cancer Res; 1986 Nov 15; 46(11):6004-10. PubMed ID: 3019543
    [Abstract] [Full Text] [Related]

  • 3. Variant forms of rat epidermal growth factor present in the urine of nude rats bearing human tumors.
    Hudgins WR, Orth DN, Stromberg K.
    Cancer Res; 1988 Mar 15; 48(6):1428-34. PubMed ID: 3257897
    [Abstract] [Full Text] [Related]

  • 4. Human A673 cells secrete high molecular weight EGF-receptor binding growth factors that appear to be immunologically unrelated to EGF or TGF-alpha.
    Stromberg K, Hudgins WR, Fryling CM, Hazarika P, Dedman JR, Pardue RL, Hargreaves WR, Orth DN.
    J Cell Biochem; 1986 Mar 15; 32(4):247-59. PubMed ID: 3492500
    [Abstract] [Full Text] [Related]

  • 5. Monoclonal antibodies specific for high molecular weight form of human epidermal growth factor.
    Koga J, Nishimuro S, Shirono H, Ito C, Yamamoto Y, Matsuo A, Kurobe M, Hayashi K.
    Biochem Int; 1989 Aug 15; 19(2):445-52. PubMed ID: 2818606
    [Abstract] [Full Text] [Related]

  • 6. Comparison of growth factors functionally related to epidermal growth factor in the urine of normal and human tumor-bearing athymic mice.
    Twardzik DR, Kimball ES, Sherwin SA, Ranchalis JE, Todaro GJ.
    Cancer Res; 1985 May 15; 45(5):1934-9. PubMed ID: 3872712
    [Abstract] [Full Text] [Related]

  • 7. Purification and characterization of a novel transforming growth factor.
    Halper J, Moses HL.
    Cancer Res; 1987 Sep 01; 47(17):4552-9. PubMed ID: 2887280
    [Abstract] [Full Text] [Related]

  • 8. Distinct high-performance liquid chromatography pattern of transforming growth factor activity in urine of cancer patients as compared with that of normal individuals.
    Kimball ES, Bohn WH, Cockley KD, Warren TC, Sherwin SA.
    Cancer Res; 1984 Aug 01; 44(8):3613-9. PubMed ID: 6331653
    [Abstract] [Full Text] [Related]

  • 9. Purification of a high molecular weight form of epidermal growth factor from urine of breast cancer patients.
    Eckert K, Granetzny A, Fischer J, Grosse R.
    Biomed Biochim Acta; 1989 Aug 01; 48(1):111-20. PubMed ID: 2789043
    [Abstract] [Full Text] [Related]

  • 10. Molecular dynamics simulations of epidermal growth factor and transforming growth factor-alpha structures in water.
    Watts CR, Lovas S, Murphy RF.
    Proteins; 1998 Nov 15; 33(3):396-407. PubMed ID: 9829698
    [Abstract] [Full Text] [Related]

  • 11. High-molecular-weight transforming growth factor activity in the urine of patients with disseminated cancer.
    Sherwin SA, Twardzik DR, Bohn WH, Cockley KD, Todaro GJ.
    Cancer Res; 1983 Jan 15; 43(1):403-7. PubMed ID: 6600160
    [Abstract] [Full Text] [Related]

  • 12. Molecular nature of human epidermal growth factor (hEGF)-like immunoreactivity in human plasma.
    Kurobe M, Furukawa S, Hayashi K.
    Biochem Int; 1986 May 15; 12(5):677-83. PubMed ID: 3524570
    [Abstract] [Full Text] [Related]

  • 13. Conversion of high molecular weight human epidermal growth factor (hEGF)/urogastrone (UG) to small molecular weight hEGF/UG by mouse EGF-associated arginine esterase.
    Hirata Y, Orth DN.
    J Clin Endocrinol Metab; 1979 Sep 15; 49(3):481-3. PubMed ID: 313937
    [Abstract] [Full Text] [Related]

  • 14. Transforming growth factor (TGF) activity in human urine: synergism between TGF-beta and urogastrone.
    Twardzik DR, Sherwin SA.
    J Cell Biochem; 1985 Sep 15; 28(4):289-97. PubMed ID: 2997242
    [Abstract] [Full Text] [Related]

  • 15. A Mr 43,000 epidermal growth factor-related protein purified from the urine of breast cancer patients.
    Eckert K, Granetzny A, Fischer J, Nexø E, Grosse R.
    Cancer Res; 1990 Feb 01; 50(3):642-7. PubMed ID: 2297705
    [Abstract] [Full Text] [Related]

  • 16. Identification of epidermal growth factor as a component of the rat urinary bladder tumor-enhancing urinary fractions.
    Yura Y, Hayashi O, Kelly M, Oyasu R.
    Cancer Res; 1989 Mar 15; 49(6):1548-53. PubMed ID: 2784351
    [Abstract] [Full Text] [Related]

  • 17. Epidermal growth factor in human seminal plasma.
    Hirata Y, Uchihashi M, Hazama M, Fujita T.
    Horm Metab Res; 1987 Jan 15; 19(1):35-7. PubMed ID: 3493966
    [Abstract] [Full Text] [Related]

  • 18. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
    Chen P, Cameron R, Wang J, Vallis KA, Reilly RM.
    J Nucl Med; 2003 Sep 15; 44(9):1469-78. PubMed ID: 12960194
    [Abstract] [Full Text] [Related]

  • 19. Assessment by a two-site enzyme immunoassay of human epidermal growth factor (urogastrone) in the urine of patients with various gastrointestinal diseases including malignant tumors.
    Kurobe M, Aono M, Moriga M, Furukawa S, Hayashi K.
    Biochem Int; 1985 Dec 15; 11(6):817-23. PubMed ID: 3937528
    [Abstract] [Full Text] [Related]

  • 20. Presence of epidermal growth factor in human tears.
    Ohashi Y, Motokura M, Kinoshita Y, Mano T, Watanabe H, Kinoshita S, Manabe R, Oshiden K, Yanaihara C.
    Invest Ophthalmol Vis Sci; 1989 Aug 15; 30(8):1879-82. PubMed ID: 2788149
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.